HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Shanghai's cross-border e-commerce pilot zone gains from CIIE's spillover effect
- Pioneering deep-sea mission completed
- Foreigners back Xizang's boarding school system
- Compatriots from both sides of Taiwan Strait oppose external interference
- Ex-deputy GM of key state-owned enterprise expelled from CPC for corruption
- Legislators push stronger protections for disabled
































